Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Apr, avoid, Cayman, cessation, choose, Danish, diminish, dissolve, dividend, examination, GmbH, hand, hemophilia, impede, inin, investor, Jun, member, merger, pose, pro, rata, recombinant, reconsidered, Sandoz, secondarily, threatened, threshold, unintended, VIIa
Removed:
acquire, ANALYSISOF, applied, assumption, back, beginning, calculated, capitalized, computation, CONDITIONAND, credit, deconsolidate, deconsolidation, DISCUSSIONAND, establishment, grow, guidance, holding, initiation, licensing, lower, phase, receive, recommence, RESULTSOF, shortcut, single, therapeutic
Filing tables
Filing exhibits
Related press release
MAXY similar filings
Filing view
External links
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
I, James R. Sulat, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge the Quarterly Report of Maxygen, Inc. on Form 10-Q for the quarterly period ended June 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Maxygen, Inc.
By: | /s/ James R. Sulat | |
Name: | James R. Sulat | |
Title: | Chief Executive Officer & Chief Financial Officer | |
Date: | August 7, 2012 |